North Star Investment Management’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-200
| Closed | -$4.07K | – | 1244 |
|
|
2023
Q3 | $4.07K | Hold |
200
| – | – | ﹤0.01% | 980 |
|
|
2023
Q2 | $4.67K | Hold |
200
| – | – | ﹤0.01% | 983 |
|
|
2023
Q1 | $4.65K | Hold |
200
| – | – | ﹤0.01% | 997 |
|
|
2022
Q4 | $5.03K | Sell |
200
-100
| -33% | -$2.52K | ﹤0.01% | 970 |
|
|
2022
Q3 | $8K | Hold |
300
| – | – | ﹤0.01% | 841 |
|
|
2022
Q2 | $9K | Hold |
300
| – | – | ﹤0.01% | 848 |
|
|
2022
Q1 | $10K | Hold |
300
| – | – | ﹤0.01% | 871 |
|
|
2021
Q4 | $13K | Hold |
300
| – | – | ﹤0.01% | 849 |
|
|
2021
Q3 | $15K | Hold |
300
| – | – | ﹤0.01% | 791 |
|
|
2021
Q2 | $16K | Hold |
300
| – | – | ﹤0.01% | 770 |
|
|
2021
Q1 | $14K | Hold |
300
| – | – | ﹤0.01% | 738 |
|
|
2020
Q4 | $14K | Buy |
300
+200
| +200% | +$9.33K | ﹤0.01% | 729 |
|
|
2020
Q3 | $4K | Buy |
+100
| New | +$4K | ﹤0.01% | 876 |
|